Authors: | Mascarenhas, J.; Kosiorek, H. E.; Prchal, J. T.; Rambaldi, A.; Berenzon, D.; Yacoub, A.; Harrison, C. N.; McMullin, M. F.; Vannucchi, A. M.; Ewing, J.; O'Connell, C. L.; Kiladjian, J. J.; Mead, A. J.; Winton, E. F.; Leibowitz, D. S.; De Stefano, V.; Arcasoy, M. O.; Kessler, C. M.; Catchatourian, R.; Rondelli, D.; Silver, R. T.; Bacigalupo, A.; Nagler, A.; Kremyanskaya, M.; Sandy, L.; Salama, M. E.; Najfeld, V.; Tripodi, J.; Weinberg, R. S.; Price, L.; Goldberg, J. D.; Rampal, R. K.; Mesa, R. A.; Dueck, A. C.; Hoffman, R. |
Abstract Title: | Results of the Myeloproliferative Neoplasms - Research Consortium (MPN-RC) 112 randomized trial of pegylated interferon alfa-2a (PEG) versus hydroxyurea (HU) therapy for the treatment of high risk polycythemia vera (PV) and high risk essential thrombocythemia (ET) |
Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
Journal Title: | Blood |
Volume: | 132 |
Issue: | Suppl. 1 |
Meeting Dates: | 2018 Dec 1-4 |
Meeting Location: | San Diego, CA |
ISSN: | 0006-4971 |
Publisher: | American Society of Hematology |
Date Published: | 2018-11-29 |
Language: | English |
ACCESSION: | WOS:000454837601286 |
PROVIDER: | wos |
DOI: | 10.1182/blood-2018-99-111946 |
Notes: | Meeting Abstract: 577 -- Source: Wos |